The Food and Drug Administration agency is putting out a stern warning that the use of unauthorized diabetes management technologies could result in inaccurate blood glucose measurements or unsafe insulin dosing. This, in turn, could lead to injury requiring medical intervention or even death, according to FDA. In a press release, the agency acknowledged its awareness of patients who create …